Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00382434 · ClinicalTrials.gov registry record
Emergency Pharmacist Safety Study
A clinical trial of Adverse Drug Event, Potential Adverse Drug Event, and Quality Measures, sponsored by University of Rochester.
- Completed
- Registry status
- 10,224
- Enrollment target
- 1
- Study location
NCT00382434 is a study of Adverse Drug Event, Potential Adverse Drug Event, and Quality Measures that has completed, run by University of Rochester. The registered enrollment target is 10,224 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00382434, a study of Adverse Drug Event, Potential Adverse Drug Event, and Quality Measures, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- 10,224 participants
- Enrollment target
- 1
- Study location
Study Summary
The Emergency Department (ED) is a unique environment in medicine, and many safety mechanisms used in other hospital settings cannot be applied in the ED. For example, clinical pharmacists have traditionally provided extra layers of protection to hospital inpatients by cross-checking provider orders for appropriate dosing, contraindications, and interactions. Because medications in the ED must be accessed immediately and are often one-time doses, the use of central pharmacy services would introduce an unacceptable delay to the administration of medication. Although some hospitals have programs in place in which a pharmacist responds to the ED for cardiac arrests or trauma team activations, few have reported programs which involve a clinical pharmacist assigned exclusively to the emergency department. Nonetheless, published reports have asserted that ED-based pharmacists can increase patient safety. Although this concept appears logical, no study has attempted to show that these programs reduce potential adverse drug events in the ED. We propose to implement and optimize an ED Pharmacist (EDP) program as a safe practice intervention in a large ED. The hospital has provided funding for two permanent full time positions starting at the beginning of the award period. In the initial phase interviews of physicians, nurses, pharmacists, and patients will be conducted and the results will be used to optimize the EDP role. A large-scale chart review study will then be conducted to evaluate whether there is a reduction in frequency of potential and adverse drug events during times that the EDP is on duty. Staff perceptions of the effectiveness of this program will also be evaluated. The overall goal of this initiative is to create an effective EDP program that will decrease the rate of adverse drug events in ED patients, and to create a "toolkit" to facilitate the introduction of similar programs into other EDs. This toolkit will include a description of the formal, optimized
Conditions Studied
Interventions
- PROCEDURE presence of an emergency pharmacist in the ED
Study Locations (1)
New York
- University of Rochester Medical Center - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,224 participants |
| Start Date | 2005-08 |
| Est. Completion | 2006-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00382434
The ClinicalTrials.gov registry entry for NCT00382434 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 10,224 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Adverse Drug Event, Potential Adverse Drug Event, and Quality Measures appearing as the primary indexed condition, and to 1 intervention - of which presence of an emergency pharmacist in the ED is the first listed.
NCT00382434 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT00382434 about?
NCT00382434 is a clinical study titled "Emergency Pharmacist Safety Study". The Emergency Department (ED) is a unique environment in medicine, and many safety mechanisms used in other hospital settings cannot be applied in the ED. For example, clinical pharmacists have traditionally provided extra layers of protection to hospital inpatients by cross-checking provider orders...
What is the current status of trial NCT00382434?
This trial is currently completed. The enrollment target is 10,224 participants. The study started on 2005-08. Estimated completion is 2006-12.
What conditions does trial NCT00382434 study?
This clinical trial studies the following conditions: Adverse Drug Event, Potential Adverse Drug Event, and Quality Measures.
What interventions are being tested in trial NCT00382434?
The interventions under investigation include: presence of an emergency pharmacist in the ED (PROCEDURE).
Who is sponsoring clinical trial NCT00382434?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00382434 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.